Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

This multicentre, prospective, randomized, open‐label, blinded‐endpoint, parallel‐group, short‐term (4–5 weeks) controlled trial was conducted to investigate the superiority of the effect of reducing mean amplitude of glycaemic excursions (MAGE) during meal tolerance tests (MTTs) for the combination...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Obes Metab
主要な著者: Cho, Kyu Yong, Nomoto, Hiroshi, Nakamura, Akinobu, Kawata, Shinichiro, Sugawara, Hajime, Takeuchi, Jun, Nagai, So, Tsuchida, Kazuhisa, Omori, Kazuno, Yokoyama, Hiroki, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki
フォーマット: Artigo
言語:Inglês
出版事項: Blackwell Publishing Ltd 2019
主題:
Brief Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065098/
https://ncbi.nlm.nih.gov/pubmed/31486230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13879
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料